RVTYNEUTRAL

Revenue Growth (YoY)

7.0%

Higher than 54% of Healthcare sector peers

Updated 78h ago

Sector Performance

54th percentile

RVTY

7.0%

Sector Median

6.2%

Sector Avg

4.2%

📊

Deep Analysis

Revenue Growth (YoY) compares a company's current revenue to the same period one year earlier; Revvity's 7.0% means its revenue increased by 7% versus the prior year.

This is above the healthcare sector median of 6.2%, placing Revvity in the 54th percentile among its sector peers. The trend is not assessable because both the year-over-year change and quarter-over-quarter change are listed as N/A, and no historical values beyond the current 7.0% are provided. The combination of a single data point with no trend direction leaves investors unable to gauge whether growth is improving or slowing, raising uncertainty about future performance. This metric supports the overall NEUTRAL verdict because the growth rate is close to the sector median and lacks the trend context needed to shift the view toward bullish or bearish.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about RVTY?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

How does RVTY's Revenue Growth (YoY) compare to its sector?

RVTY's Revenue Growth (YoY) of 7.0% compares to a Healthcare sector median of 6.2%, placing it in the 54th percentile.

Who are RVTY's closest peers by Revenue Growth (YoY)?

The closest Healthcare peers by Revenue Growth (YoY) include: ALGN (6.2%), AMGN (5.8%), CPRX (5.6%), ABT (7.8%), ZBH (9.3%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.